Searching for Optimal Prognostic Marker of Heart Failure Progression in the Era of ARNI

Angiotensin receptor-neprilysin inhibitor (ARNI) brought unquestionable value to heart failure (HF) therapy. However, there is still uncertainty regarding monitoring of treatment effects. Although a subanalysis of the PARADIGM-HF (Prospective Comparison of ARNI with ACEI to Determine Impact on